Pricing
Login
Home
Charts
Search
Watchlist
Products

Sotac Pharmaceuticals Ltd

SOTAC
₹135.00+4.65%20 Nov 2026
Reports
Pharma CRAMS

Sotac Pharmaceuticals Ltd

SOTAC
₹135.00
+4.65%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹149Cr
Close
Close Price
₹135.00
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
17.26
PS
Price To Sales
1.09
Revenue
Revenue
₹137Cr
Rev Gr TTM
Revenue Growth TTM
54.68%
PAT Gr TTM
PAT Growth TTM
-3.37%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
20403852525347416077
Growth YoY
Revenue Growth YoY%
29.938.31.8-9.7-21.727.485.9
Expenses
ExpensesCr
18363447484835335065
Operating Profit
Operating ProfitCr
1344441281012
OPM
OPM%
7.38.610.28.67.48.225.619.016.815.3
Other Income
Other IncomeCr
0100010001
Interest Expense
Interest ExpenseCr
0111112222
Depreciation
DepreciationCr
1111212333
PBT
PBTCr
133434116811
Tax
TaxCr
0111111112
PAT
PATCr
0111228346
Growth YoY
PAT Growth YoY%
17.687.447.5215.646.3-50.7134.0
NPM
NPM%
1.22.63.42.34.63.415.96.36.27.9
EPS
EPS₹
0.34.41.61.62.31.75.52.23.04.8
QuarterJun 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
20403852525347416077
Growth YoY
Revenue Growth YoY%
29.938.31.8-9.7-21.727.485.9
Expenses
ExpensesCr
18363447484835335065
Operating Profit
Operating ProfitCr
1344441281012
OPM
OPM%
7.38.610.28.67.48.225.619.016.815.3
Other Income
Other IncomeCr
0100010001
Interest Expense
Interest ExpenseCr
0111112222
Depreciation
DepreciationCr
1111212333
PBT
PBTCr
133434116811
Tax
TaxCr
0111111112
PAT
PATCr
0111228346
Growth YoY
PAT Growth YoY%
17.687.447.5215.646.3-50.7134.0
NPM
NPM%
1.22.63.42.34.63.415.96.36.27.9
EPS
EPS₹
0.34.41.61.62.31.75.52.23.04.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
29497710497101137
Growth
Revenue Growth%
70.834.0-6.64.454.7
Expenses
ExpensesCr
274770958383115
Operating Profit
Operating ProfitCr
2179141822
OPM
OPM%
6.53.09.48.214.117.715.9
Other Income
Other IncomeCr
0000401
Interest Expense
Interest ExpenseCr
0122344
Depreciation
DepreciationCr
1323456
PBT
PBTCr
0-24411919
Tax
TaxCr
0020223
PAT
PATCr
0-2249610
Growth
PAT Growth%
-2,803.356.6159.1-32.1-3.4
NPM
NPM%
0.3-4.83.03.59.66.27.1
EPS
EPS₹
0.9-10.33.63.97.35.27.8
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
29497710497101137
Growth
Revenue Growth%
70.834.0-6.64.454.7
Expenses
ExpensesCr
274770958383115
Operating Profit
Operating ProfitCr
2179141822
OPM
OPM%
6.53.09.48.214.117.715.9
Other Income
Other IncomeCr
0000401
Interest Expense
Interest ExpenseCr
0122344
Depreciation
DepreciationCr
1323456
PBT
PBTCr
0-24411919
Tax
TaxCr
0020223
PAT
PATCr
0-2249610
Growth
PAT Growth%
-2,803.356.6159.1-32.1-3.4
NPM
NPM%
0.3-4.83.03.59.66.27.1
EPS
EPS₹
0.9-10.33.63.97.35.27.8
Sales CAGR
1 Year4%
3 Years9%
5 Years29%
TTM16%
EBITDA CAGR
1 Year31%
3 Years35%
5 Years57%
TTM154%
PAT CAGR
1 Year-32%
3 Years40%
5 Years134%
TTM200%
Avg. ROCE
1 Year13%
3 Years12%
5 Years10%
TTM22%
CFO / EBITDA
1 Year94%
3 Years-9%
5 Years9%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
22811111111
Reserves
ReservesCr
10234424853
Current Liabilities
Current LiabilitiesCr
192346445258
Non Current Liabilities
Non Current LiabilitiesCr
698121411
Total Liabilities
Total LiabilitiesCr
303574105124133148
Current Assets
Current AssetsCr
141747617078
Non Current Assets
Non Current AssetsCr
171727455556
Total Assets
Total AssetsCr
303574105124133148
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
22811111111
Reserves
ReservesCr
10234424853
Current Liabilities
Current LiabilitiesCr
192346445258
Non Current Liabilities
Non Current LiabilitiesCr
698121411
Total Liabilities
Total LiabilitiesCr
303574105124133148
Current Assets
Current AssetsCr
141747617078
Non Current Assets
Non Current AssetsCr
171727455556
Total Assets
Total AssetsCr
303574105124133148

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
008-16-417
Investing Cash Flow
Investing Cash FlowCr
-12-3-12-20-14-7
Financing Cash Flow
Financing Cash FlowCr
113132916-10
Net Cash Flow
Net Cash FlowCr
0010-6-20
Free Cash Flow
Free Cash FlowCr
-10-30-29-2111
CFO To PAT
CFO To PAT%
65.113.0356.2-449.1-46.9267.8
CFO To EBITDA
CFO To EBITDA%
3.1-21.1112.3-188.8-31.994.2
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
008-16-417
Investing Cash Flow
Investing Cash FlowCr
-12-3-12-20-14-7
Financing Cash Flow
Financing Cash FlowCr
113132916-10
Net Cash Flow
Net Cash FlowCr
0010-6-20
Free Cash Flow
Free Cash FlowCr
-10-30-29-2111
CFO To PAT
CFO To PAT%
65.113.0356.2-449.1-46.9267.8
CFO To EBITDA
CFO To EBITDA%
3.1-21.1112.3-188.8-31.994.2

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
134131121149
Price To Earnings
Price To Earnings
31.316.420.917.3
Price To Sales
Price To Sales
1.31.31.21.1
Price To Book
Price To Book
3.02.52.02.5
EV To EBITDA
EV To EBITDA
18.212.78.88.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.814.519.215.121.526.826.8
OPM
OPM%
6.53.09.48.214.117.715.9
NPM
NPM%
0.3-4.83.03.59.66.27.1
ROCE
ROCE%
4.2-5.318.48.114.113.321.8
ROE
ROE%
2.9-94.922.97.917.410.715.2
ROA
ROA%
0.3-6.83.13.47.54.76.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
134131121149
Price To Earnings
Price To Earnings
31.316.420.917.3
Price To Sales
Price To Sales
1.31.31.21.1
Price To Book
Price To Book
3.02.52.02.5
EV To EBITDA
EV To EBITDA
18.212.78.88.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.814.519.215.121.526.826.8
OPM
OPM%
6.53.09.48.214.117.715.9
NPM
NPM%
0.3-4.83.03.59.66.27.1
ROCE
ROCE%
4.2-5.318.48.114.113.321.8
ROE
ROE%
2.9-94.922.97.917.410.715.2
ROA
ROA%
0.3-6.83.13.47.54.76.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,9841,81223014912812390
Close PriceClose₹961.25115.57207.00135.00158.0057.0868.51
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE30.4117.5417.2617.3429.66
Price To SalesPS2.190.662.281.091.834.580.93
RevenueRevenueCr9042,756101137702797
Revenue Growth TTMRev Gr TTM%19.0%-0.1%22.3%54.7%-1.4%114.4%
PAT Growth TTMPAT Gr TTM%8.9%-184.9%44.5%-3.4%51.4%410.3%
Market CapitalizationMkt CapCr1,9841,81223014912812390
Close PriceClose₹961.25115.57207.00135.00158.0057.0868.51
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE30.4117.5417.2617.3429.66
Price To SalesPS2.190.662.281.091.834.580.93
RevenueRevenueCr9042,756101137702797
Revenue Growth TTMRev Gr TTM%19.0%-0.1%22.3%54.7%-1.4%114.4%
PAT Growth TTMPAT Gr TTM%8.9%-184.9%44.5%-3.4%51.4%410.3%
Annual Reports
FY2025
FY2024
FY2023
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Load More
Interviews